share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Apr 1 08:08

Gainers

  • Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. The market value of their outstanding shares is at $12.3 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Sunshine Biopharma (NASDAQ:SBFM) shares rose 46.11% to $0.09. The company's market cap stands at $8.7 million.
  • Qilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 44.94% to $1.0. The market value of their outstanding shares is at $35.7 million.
  • Xilio Therapeutics (NASDAQ:XLO) stock moved upwards by 27.77% to $1.38. The market value of their outstanding shares is at $37.9 million.
  • Innate Pharma (NASDAQ:IPHA) shares moved upwards by 18.05% to $3.4. The company's market cap stands at $274.8 million.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) stock rose 14.76% to $0.43.

Losers

  • ENDRA Life Sciences (NASDAQ:NDRA) shares decreased by 29.3% to $0.41 during Monday's pre-market session. The market value of their outstanding shares is at $4.5 million. The company's, Q4 earnings came out 2 days ago.
  • SINTX Techs (NASDAQ:SINT) shares declined by 21.42% to $0.04. As per the news, the Q4 earnings report came out 3 days ago.
  • Fractyl Health (NASDAQ:GUTS) shares declined by 20.95% to $5.85. The market value of their outstanding shares is at $278.5 million.
  • Vivos Therapeutics (NASDAQ:VVOS) shares declined by 17.19% to $4.0. The company's market cap stands at $5.3 million. The company's, Q4 earnings came out 2 days ago.
  • Avalo Therapeutics (NASDAQ:AVTX) stock fell 16.55% to $18.15. The market value of their outstanding shares is at $14.5 million.
  • Applied Therapeutics (NASDAQ:APLT) stock declined by 14.56% to $5.81. The company's market cap stands at $615.2 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment